Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA. | Cell Rep | 2022 | 36223747 | PubTator, text mining | PubMed |
| The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules. | EMBO Rep | 2022 | 36215666 | PubTator, text mining | PubMed |
| KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma. | Biomed Res Int | 2022 | 36212716 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| Activation and regulation mechanisms of NOD-like receptors based on structural biology. | Front Immunol | 2022 | 36189327 | PubTator, text mining | PubMed |
| NOD-like receptors in asthma. | Front Immunol | 2022 | 36189256 | PubTator, text mining | PubMed |
| Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. | Front Pharmacol | 2022 | 36188615 | PubTator, text mining | PubMed |
| Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses. | Cancer Cell | 2022 | 36179686 | Swiss-Prot, curated | PubMed |
| CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. | Sci Adv | 2022 | 36179026 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy. | MedComm (2020) | 2022 | 36176733 | PubTator, text mining | PubMed |
| A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy. | Front Immunol | 2022 | 36159801 | PubTator, text mining | PubMed |
| Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria. | Front Immunol | 2022 | 36159783 | PubTator, text mining | PubMed |
| Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity. | Nat Commun | 2022 | 36153324 | PubTator, text mining | PubMed |
| Protein arginine methyltransferase 1 in the generation of immune megakaryocytes: A perspective review. | J Biol Chem | 2022 | 36152748 | PubTator, text mining | PubMed |
| Over-expression of NFYB affects stromal cells reprogramming and predicts worse survival in gastric cancer patients. | Aging (Albany NY) | 2022 | 36152055 | PubTator, text mining | PubMed |
| NOD1, NOD2, and NLRC5 Receptors in Antiviral and Antimycobacterial Immunity. | Vaccines (Basel) | 2022 | 36146565 | PubTator, text mining | PubMed |
| mRNA Metabolism in Health and Disease. | Biomedicines | 2022 | 36140363 | PubTator, text mining | PubMed |
| Olanzapine Ameliorates Ischemic Stroke-like Pathology in Gerbils and H2O2-Induced Neurotoxicity in SH-SY5Y Cells via Inhibiting the MAPK Signaling Pathway. | Antioxidants (Basel) | 2022 | 36139770 | PubTator, text mining | PubMed |
| Typical Enhancers, Super-Enhancers, and Cancers. | Cancers (Basel) | 2022 | 36139535 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic alterations in offspring born to women with type 1 diabetes (the EPICOM study). | BMC Med | 2022 | 36138412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=33